tablets and smartphones) that can be owned by KBCC or the end-user, it is critical to develop a unified management strategy that mitigates risks, while providing maximum flexibility to students, faculty and staff.
The solution enables KBCC to make critical decisions with confidence.
The complete text of the KBCC case study can be found: http://www.
Founded in 1998 by the Korean Ministry of Commerce, Industry, and Energy, KBCC provides contract manufacturing services for the production of biopharmaceuticals including genetically engineered protein and monoclonal antibody therapeutics.
PAREXEL's BioPharm Alliance partner, Sartorius AG, a leading laboratory and process technology supplier, maintains a local presence in Seoul, South Korea, and will provide critical bioprocess equipment to be validated by PAREXEL Consulting at KBCC.